{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:40Z","timestamp":1790775760552,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001837","name":"Eesti Teadusfondi","doi-asserted-by":"publisher","award":["7479"],"award-info":[{"award-number":["7479"]}],"id":[{"id":"10.13039\/501100001837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003081","name":"Ministry of Education, Ethiopia","doi-asserted-by":"publisher","award":["SF0180043s07"],"award-info":[{"award-number":["SF0180043s07"]}],"id":[{"id":"10.13039\/501100003081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003081","name":"Ministry of Education, Ethiopia","doi-asserted-by":"publisher","award":["SF0180148s08"],"award-info":[{"award-number":["SF0180148s08"]}],"id":[{"id":"10.13039\/501100003081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007821","name":"Tartu \u00dclikool","doi-asserted-by":"publisher","award":["PARFS 07915"],"award-info":[{"award-number":["PARFS 07915"]}],"id":[{"id":"10.13039\/501100007821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008369","name":"Sihtasutus Archimedes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008369","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.humimm.2012.01.011","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T19:36:03Z","timestamp":1328038563000},"page":"393-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells"],"prefix":"10.1016","volume":"73","author":[{"given":"Ene","family":"Reimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fclli","family":"Kingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maire","family":"Karelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Reemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulvi","family":"Loite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Sulakatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maris","family":"Keermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Raud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Abram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Vasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Silm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulev","family":"K\u00f5ks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2012.01.011_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08916930108994127","article-title":"Autoimmune aspects of vitiligo","volume":"34","author":"Kemp","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1016\/j.humimm.2012.01.011_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.humimm.2012.01.011_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0738-081X(97)00125-9","article-title":"Pathophysiology of vitiligo","volume":"15","author":"Castanet","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1346-8138.1997.tb02292.x","article-title":"Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo","volume":"24","author":"Honda","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.humimm.2012.01.011_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.humimm.2012.01.011_bib8","first-page":"799","article-title":"Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment","volume":"26","author":"Zailaie","year":"2005","journal-title":"Saudi Med J"},{"issue":"1 Suppl","key":"10.1016\/j.humimm.2012.01.011_bib9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jaad.2004.01.007","article-title":"White patches and bruised souls: Advances in the pathogenesis and treatment of vitiligo","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri1153","article-title":"Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators","volume":"3","author":"Renauld","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humimm.2012.01.011_bib11","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.172.4.2006","article-title":"Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2","volume":"172","author":"Sheikh","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.01.011_bib12","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.171303198","article-title":"A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2012.01.011_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.intimp.2004.01.007","article-title":"Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization","volume":"4","author":"Nagalakshmi","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.humimm.2012.01.011_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biochi.2007.01.008","article-title":"IL-28 and IL-29: Newcomers to the interferon family","volume":"89","author":"Uz\u00e9","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.humimm.2012.01.011_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2008.08785.x","article-title":"Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera","volume":"159","author":"R\u00e4tsep","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib17","doi-asserted-by":"crossref","first-page":"49668","DOI":"10.1074\/jbc.M208593200","article-title":"MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination","volume":"277","author":"Badciong","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humimm.2012.01.011_bib18","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1073\/pnas.0508500103","article-title":"Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development","volume":"103","author":"Xiong","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2012.01.011_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.humimm.2012.01.011_bib20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1046\/j.1523-1747.1999.00566.x","article-title":"Expression of interferon-beta is associated with growth arrest of murine and human epidermal cells","volume":"112","author":"Bielenberg","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/cyto.2002.1028","article-title":"Interferon-beta from melanoma cells suppresses the proliferations of melanoma cells in an autocrine manner","volume":"18","author":"Satomi","year":"2002","journal-title":"Cytokines"},{"key":"10.1016\/j.humimm.2012.01.011_bib22","first-page":"172","article-title":"Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells","volume":"49","author":"Lu","year":"2002","journal-title":"J Med Invest"},{"key":"10.1016\/j.humimm.2012.01.011_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","article-title":"Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection","volume":"21","author":"Se\u00e7kin","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1567-5769(01)00184-9","article-title":"Immunomodulation as a treatment strategy for genital herpes: Review of the evidence","volume":"2","author":"Miller","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.humimm.2012.01.011_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/mthe.2001.0464","article-title":"Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models","volume":"4","author":"Qin","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.humimm.2012.01.011_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0090-1229(88)90023-2","article-title":"Examination of the inhibitory and stimulatory effects of IFN-alpha, -beta, and -gamma on human B-cell proliferation induced by various B-cell mitogens","volume":"48","author":"Francois","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"issue":"Suppl","key":"10.1016\/j.humimm.2012.01.011_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.10.001","article-title":"Physiopathology and genetics of vitiligo","volume":"25","author":"Passeron","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.humimm.2012.01.011_bib28","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1111\/j.1468-1331.2009.02563.x","article-title":"Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: A case report","volume":"16","author":"Kocer","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.humimm.2012.01.011_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv Immunol"},{"key":"10.1016\/j.humimm.2012.01.011_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2133.1998.02550.x","article-title":"Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules","volume":"139","author":"Hedley","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humimm.2012.01.011_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3349\/ymj.1994.35.4.404","article-title":"Immunohistochemical studies from vitiligo\u2014comparison between active and inactive lesions","volume":"35","author":"Ahn","year":"1994","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.humimm.2012.01.011_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711690205","article-title":"Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo","volume":"169","author":"al Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.humimm.2012.01.011_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2012.01.011_bib34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: Implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.humimm.2012.01.011_bib35","doi-asserted-by":"crossref","first-page":"17150","DOI":"10.1016\/S0021-9258(18)37511-2","article-title":"A gene amplified in a transformed mouse cell line undergoes complex transcriptional processing and encodes a nuclear protein","volume":"263","author":"Snyder","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humimm.2012.01.011_bib36","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1093\/hmg\/ddn295","article-title":"Age-related retinal degeneration (arrd2) in a novel mouse model due to a nonsense mutation in the Mdm1 gene","volume":"17","author":"Chang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humimm.2012.01.011_bib37","first-page":"19","article-title":"Vitiligo with raised inflammatory borders: Involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM-1 molecules","volume":"7","author":"Yagi","year":"1997","journal-title":"Eur J Dermatol Clin"},{"key":"10.1016\/j.humimm.2012.01.011_bib38","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:49:38Z","timestamp":1759319378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885912000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0198885912000213"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2012.01.011","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2012.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}